The choline pathway as a strategy to promote central nervous system (CNS) remyelination

Neural Regeneration Research

Volumn 10, Issue 9, 2015, Pages 1369-1370

  Skripuletz, Thomas ^a   Linker, Ralf A ^b   Stangel, Martin ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CITICOLINE; CUPRIZONE; CYTIDINE PHOSPHATE; DIACYLGLYCEROL; LINGO 1 ANTAGONIST; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DIARRHEA; EVOKED VISUAL RESPONSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GLIA CELL; HEADACHE; HUMAN; LD50; MESENCHYMAL STEM CELL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NOTE; OLIGODENDROCYTE PRECURSOR CELL; REMYELINIZATION; RETINAL NERVE FIBER LAYER THICKNESS; STOMACH PAIN;

EID: 84942109437     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.165498     Document Type: Note

References (10)

1. Adibhatla RM, Hatcher JF (2002) Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res 70:133-139.
2. Davalos A, Alvarez-Sabin J, Castillo J, Diez-Tejedor E, Ferro J, Martinez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ (2012) Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 380:349-357.
3. Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839-855.
4. Grieb P (2014) Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs 28:185-193.
5. Grieb P (2015) Beneficial effects of exogenous CDP-cholinę (citicoline) in EAE. Brain doi: 10.1093/brain/awv140.
6. Hjelmstad RH, Bell RM (1991) Molecular insights into enzymes of membrane bilayer assembly. Biochemistry 30:1731-1740.
7. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B (2009) Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 65:304-315.
8. Skripuletz T, Gudi V, Hackstette D, Stangel M (2011) De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol 26:1585-1597.
9. Skripuletz T, Manzel A, Gropengiesser K, Schafer N, Gudi V, Singh V, Salinas TL, Jorg S, Hammer A, Voss E, Vulinovic F, Degen D, Wolf R, Lee DH, Pul R, Moharregh-Khiabani D, Baumgartner W, Gold R, Linker RA, Stangel M (2015) Pivotal role of choline metabolites in remyelination. Brain 138:398-413.
10. Zafonte RD, Bagiella E, Ansel BM, Novack TA, Friedewald WT, Hesdorffer DC, Timmons SD, Jallo J, Eisenberg H, Hart T, Ricker JH, Diaz-Arrastia R, Merchant RE, Temkin NR, Melton S, Dikmen SS (2012) Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 308:1993-2000.